Jay Bhattacharya, nominee for National Institutes of Health director, and FDA pick Marty Makary clear key Senate committee.

President Donald Trump's nominee to lead the Food and Drug Administration (FDA) Dr. Marty Makary passed a key committee vote on Thursday morning.

The delays and frequent queries raised by CDSCO have become a major obstacle for applicants, particularly startups and ...

The study found that just 20% of trials submitted to both the FDA and European Medicines Agency had matching evidence.

Dyne Therapeutics’ DYNE-101 shows positive results in phase 1/2 ACHIEVE study. Read why DYN stock may rise with FDA approval and a $2.78B market opportunity.

The latest HPRA inspection in February 2025 was highly successful-both QC licences were renewed, and viral vector manufacturing was added to the MIA (IMP) licence. This means the Shannon site can ...

Amid the ethical and legal arguments, a fundamental question remains: How much do we truly understand about the drugs used in ...

To be a person in the year 2025 is to encounter, in one way or another, the marketing onslaught for compounded ...

Treatments for dry eye disease, neuroendocrine tumors, chronic spontaneous urticaria, Barth syndrome, and migraine are under review.

FLORHAM PARK, N.J., March 13, 2025 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical ...

Recent FDA feedback received on SER-155 allogeneic hematopoietic stem cell transplant (allo-HSCT) next study provides support for the proposed ...

The move marks an advancement in reducing plastic waste and assisting global brands in achieving their sustainability ...